Cuba teams with China's Lukang to manufacture biotech products; Catalent, BASF take on solubility challenges;

> Cuba's Center for Genetic Engineering and Biotechnology and Lukang Pharmaceutical in China announced plans to cooperatively manufacture and market biotechnology products. Item

> Catalent and BASF will jointly market technology to address drug solubility issues to help companies formulate optimal dose form from development through scale-up and supply. Story

> Nepal's Department of Drug Administration is writing good manufacturing practice (GMP) regulations that will meet World Health Organization (WHO) standards in expectation of raising drug manufacturing standards and making the country's pharmaceuticals more acceptable internationally. Article

> US Pharmacopeia (USP) is investing $1.5 million and looking for donors to set up a facility which will fund itself offering quality control services to pharmaceutical manufacturers in Sub-Saharan Africa. Story

> Omkar Specialty Chemicals in India has acquired LASA Laboratory, which has an API manufacturing facility that makes mostly active ingredients for veterinary pharmaceuticals. More

Suggested Articles

CureVac and Tesla are teaming up to produce the German vaccine maker's molecular RNA printers, Tesla CEO Elon Musk tweeted Thursday.

The FDA knocked a California compounding pharmacy facility for a suite of sanitary concerns, including the presence of ants in the plant.

Merck Animal Health will plow $100 million into its DeSoto, Kansas, plant to scale up production of animal vaccines.